203 related articles for article (PubMed ID: 22114782)
1. Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.
Arranz MJ; Munro JC
Expert Rev Clin Pharmacol; 2011 May; 4(3):389-405. PubMed ID: 22114782
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics and tailored drug treatment in schizophrenia].
Andreassen OA; Steen VM
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and schizophrenia.
Foster A; Miller DD; Buckley PF
Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of antipsychotic treatment in schizophrenia.
Pouget JG; Müller DJ
Methods Mol Biol; 2014; 1175():557-87. PubMed ID: 25150876
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
8. The impact of pharmacogenetics on the development and use of antipsychotic drugs.
Reynolds GP
Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic approaches to cognitive enhancement in schizophrenia.
Burdick KE; Gopin CB; Malhotra AK
Harv Rev Psychiatry; 2011; 19(3):102-8. PubMed ID: 21631157
[TBL] [Abstract][Full Text] [Related]
10. Model-based gene selection shows engrailed 1 is associated with antipsychotic response.
Webb BT; Sullivan PF; Skelly T; van den Oord EJ
Pharmacogenet Genomics; 2008 Sep; 18(9):751-9. PubMed ID: 18698228
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of antipsychotics: useful for the clinician?
Bondy B; Spellmann I
Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenetics of antipsychotics in schizophrenia].
Méary A
Therapie; 2008; 63(3):243-6. PubMed ID: 18718213
[TBL] [Abstract][Full Text] [Related]
13. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
[TBL] [Abstract][Full Text] [Related]
14. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
Reynolds GP; Templeman LA; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of treatment effects in schizophrenia.
Stroup TS
Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of response to antipsychotics in patients with schizophrenia.
Arranz MJ; Rivera M; Munro JC
CNS Drugs; 2011 Nov; 25(11):933-69. PubMed ID: 22054119
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics can improve antipsychotic treatment in schizophrenia.
Xu Q; Wu X; Xiong Y; Xing Q; He L; Qin S
Front Med; 2013 Jun; 7(2):180-90. PubMed ID: 23606027
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.
Scolnick EM
Biol Psychiatry; 2006 Jun; 59(11):1039-45. PubMed ID: 16616720
[TBL] [Abstract][Full Text] [Related]
20. [Receptor polymorphism and response to treatment in schizophrenia].
Szekeres G; Janka Z
Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
